Reports Library Publication
M&A Watch: Strategic M&A Intelligence Service from Deal Advisors Specialised in Consumer Healthcare
28th November 2025 by Nicholas Hall's M&A Team
How every dealmaker can create long-term value in a consolidating Consumer Healthcare market
Interest in M&A is peaking in the Consumer Healthcare sector but the industry has become very short-term in its attitudes and uncertainty is higher than ever. More than 150 significant transactions completed since 2020, buyers pay high premium for speed-to-scale and immediate market access, but many deals fail to deliver value to shareholders, the acquired company, and brands.
That’s why we have developed M&A Watch, a first-of-its-kind service dedicated to Consumer Healthcare dealmaking, to help you make decisions with confidence when you buy-to-build or divest.
Start your M&A Watch journey today: focus your acquisition strategy, buy well, build long-term growth and exit high!
M&A Watch Foundation Report builds the fundamental strategic framework for successful dealmaking in the Consumer Healthcare sector, drawing on the analyses of 150+ recent acquisitions.
With your M&A Watch Subscription, you will get objective and critical insights into the global M&A landscape month-on-month to understand the playbook and more importantly what is ahead. Our “Spot the Deal” module is focused on prospects, and ideal if you are actively seeking opportunities and want a balanced view on market potential and prospective targets.
Our annual subscription modules offer customised M&A support and high return on investment. Ask for a quote today!
For more information, please contact Chirag Sharma, Associate Director, M&A via chirag@nicholashall.com
Order this report
First edition Foundation Report Now Available
Why buy this report?
"M&A in the Consumer Health sector is at an all-time recent high. Although the number of deals is down, the average deal value in 2025 is €2.9bn reflecting two mega-deals, CD&R’s purchase of a controlling 50% stake in Opella and CapVest’s acquisition of Stada after its owner’s two-year search for a cash-out. Although these deals are likely to be profitable, many deals fail to deliver value to shareholders, the acquired businesses and the CHC market.
That's why we have launched M&A Watch, a three-tier service, starting with the M&A Watch Foundation Report which will help to navigate the complexities of Consumer Healthcare M&A on both the buy and sell side.
The subscription modules will give you forward-looking strategic support customised to your needs."
Nicholas Hall